1) National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Colon Cancer, 2012, Version 2.
2) Lembersky BC, Wieand HS, Petrelli NJ, et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon : results from Na-tional Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 2006 ; 24 : 2059.
3) Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005 ; 352 : 2696.
4) Saltz LB, Niedzwiecki D, Hollis D, et al. Irinotecan fluorouracil plus leucovorin is not superior to fluo- rouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer : results of CALGB 89803. J Clin Oncol 2007 ; 25 : 3456.
5) Van Cutsem E, Labianca R, Bodoky G, et al. Ran- domized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III co- lon cancer : PETACC-3. J Clin Oncol 2009 ; 27 : 3117.